Portland, OR -- (SBWIRE) -- 05/18/2018 -- The report provides a detailed analysis of the entire U.S. medical grade sodium bicarbonate industry, covering the key market segments, market landscape, major market players, the research methodology, market size by segment and region, market dynamics, market forecast, Porters analysis, trends analysis, and key market players. The information provided in the report is a result of an extensive research of the global U.S. medical grade sodium bicarbonate market with opinions from industry experts. The research methodology is provided in terms of primary and secondary research methods implemented to gather and validate data.

Request for a sample report of U.S. Medical Grade Sodium Bicarbonate Market:

The U.S. medical grade sodium bicarbonate market report is a useful resource for market players, investors, stakeholders, and new entrants to understand the overall market status for the historic period 2014-2017 and the forecast period 2018-2025. It also helps in devising plans for expansion and determining opportunities for business growth.

An executive summary of the global U.S. medical grade sodium bicarbonate market is provided based on the key findings, market attractiveness and trends analysis, and competitive landscape. Market landscape is provided in the study based on growth drivers, Porters Five Forces Analysis, and market share analysis. The market drivers and restraints assist in analyzing the elements influencing the growth of the global U.S. medical grade sodium bicarbonate industry. The Porters Five Forces Analysis (PFFA) is offered in the study based on the bargaining power of buyers and suppliers, the threat of new entrants, threat from substitutes, and industrial rivalry. This analysis provides insights into the industry rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the market. Market share analysis is based on the industry segmentation and it is valuable as it helps determine how well the players are doing in the market as compared to their competitors.

Get 20% Discount On Customization:

With the help of the drivers, opportunities, and restraints, the report explains why the industry growth rises or slows down. The demand for U.S. medical grade sodium bicarbonate is growing due to the high occurrence of disorders related to acidosis, the rise in demand for sodium bicarbonate during heart surgery, and the rise in number of patients undergoing chemotherapy. In addition, an increase in demand for use of the drug in heart surgery and chemotherapy treatment provides a major opportunity for market expansion. Nonetheless, the negative effects such as headache, nausea, and irritability due to high dose of the medicine is likely to impede the growth of the industry.

A detailed segmentation of the U.S. medical grade sodium bicarbonate market is provided in the report based on the state. By state, the market analysis is covered for Arizona, Nevada, New Mexico, Utah, Colorado, Oregon, Washington, and Hawaii. The state of Arizona is likely to garner $2.41 million by 2025, growing at a CAGR of 5.6% during the forecast period, 2018-2025. New Mexico is likely to grow at a CAGR of 6.3% during the forecast period. The state of Colorado is expected to grow at a CAGR of 5.8%. The states of Oregon and Washington are anticipated to reach $1.54 million and $1.6 million by 2025 respectively.

The report offers a detailed analysis of the major market players operating in the U.S. medical grade sodium bicarbonate market. An overview of each player is provided along with the insights into their business segments and recent developments. These information help market players gain an understanding of the competitive market scenario and devise strategies to be adopted to gain competitive advantage. The top operating players in the global U.S. medical grade sodium bicarbonate industry include Amphastar Pharmaceuticals, Inc., Hospira, Inc. (Pfizer), Cardinal Health, Athenex, Inc., Nephron Pharmaceuticals Corporation, QuVa Pharma, Inc., Rugby Laboratories, Richmond Pharmaceuticals, Inc., and Menper Distributors Inc